Quantcast
Home > Quotes > INNT

Innovate Biopharmaceuticals, Inc. Common Stock (INNT) Quote & Summary Data

INNT 
$1.97
*  
0.10
4.83%
Get INNT Alerts
*Delayed - data as of Mar. 22, 2019  -  Find a broker to begin trading INNT now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
35
Today's High / Low
$ 2.13 / $ 1.87
Share Volume
819,564
50 Day Avg. Daily Volume
378,868
Previous Close
$ 2.07
52 Week High / Low
$ 50.50 / $ 1.70
Market Cap
59,631,679
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
-0.17

Intraday Chart

Shares Traded

Share Volume:
819,564
50 Day Avg. Daily Volume:
378,868

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -1.06

Trading Range

The current last sale of $1.97 is 15.88% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 2.13 $ 50.50
 Low: $ 1.87 $ 1.70

Company Description (as filed with the SEC)

On January 29, 2018, Monster Digital, Inc. ("Monster") and privately held Innovate Biopharmaceuticals Inc. ("Private Innovate") completed a reverse recapitalization in accordance with the terms of the Agreement and Plan of Merger and Reorganization, dated July 3, 2017, as amended (the "Merger Agreement"), by and among Monster, Monster Merger Sub, Inc. ("Merger Sub") and Private Innovate, which changed its name in connection with the transaction to IB Pharmaceuticals Inc. ("IB Pharmaceuticals"). Pursuant to the Merger Agreement, Merger Sub merged with and into IB Pharmaceuticals with IB Pharmaceuticals surviving as the wholly owned subsidiary of Monster (the "Merger"). Immediately following the Merger, Monster changed its name to Innovate Biopharmaceuticals, Inc. ("Innovate"). In connection with the closing of the Merger, Innovate's common stock began trading on the Nasdaq Capital Market under the ticker symbol "INNT" on February 1, 2018.  ... More ...  



Risk Grade

Where does INNT fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 2.08
Open Date:
Mar. 22, 2019
Close Price:
$ 1.97
Close Date:
Mar. 22, 2019


Consensus Recommendation

Analyst Info